Dr. Vidur Garg

Doctor Image

Dr. Vidur Garg

MBBS, MCH (Surgical Oncology)

I am currently working in Narayana Hospital Gurugram trained in various disease management groups, assisting with day-to-day surgeries including advanced laparoscopic techniques. My goal is to serve the cancer patient, promote education, and do research.

Speciality: Surgical Oncologist
Degrees: MBBS, MS, MCH
Areas of Expertise: Robotic Surgery
Laparoscopic Surgery
CRS+HIPEC
VATS
Office: Lower Basement, Narayana Superspeciality Hospital, DLF Phase 3, Sector 24, Gurugram, Haryana
Experience: Tata Memorial Hospital Mumbai, MPMMCC and HBCH, NRS Kolkata
OPD Timing

Narayana Hospital, Gurugram

Monday 9:00 am - 5:00 pm
Tuesday 9:00 am - 5:00 pm
Wednesday 9:00 am - 5:00 pm
Thursday 9:00 am - 5:00 pm
Friday 9:00 am - 5:00 pm
Saturday 9:00 am - 5:00 pm
Sunday Closed

Get In Touch

Get Appointment

Prognostic nutritional index (PNI) correlates with postoperative complications and survival in colorectal cancers. Separate studies for rectal cancers are not available where the majority have preoperative radiation, operated by minimally invasive approaches and have diverting ostomies.Consecutive rectal resections between October 2014 and December 2017 from a single center were included. PNI was calculated as 10 x (serum Albumin) + 0.005 x TLC (per mm3) before operation. Multivariate cox regression was used with overall survival (OS) as the dependent variable. Interaction terms of PNI with neoadjuvant therapy, surgical approach and postoperative complications were used to assess specific subgroups.Three-hundred forty elective rectal resections were included with a mean PNI of 46.711 (SD – 6.692), and a median follow up of 44 mo. In multivariable regression, PNI predicted OS (HR – 0.943; p-0.001). Interaction of PNI with preoperative radiation or surgical approach (open, laparoscopic, or robotic) did not change its influence on survival. PNI predicted survival with similar hazard even in patients without major postoperative complicationsDespite routine diversion after rectal resections, PNI predicted OS with an absolute survival benefit of 1.2% at 3-year for every unit increase in PNI irrespective of preoperative therapy or surgical approach.

There is an ongoing unmet need of early identification and discussion regarding the sexual and urinary dysfunction in the peri-operative period to improve the quality of life (QoL), particularly in young rectal cancer survivors. Retrospective analysis of prospectively maintained database was done. Male patients less than 60 years who underwent nerve preserving, sphincter sparing rectal cancer surgery between January 2013 and December 2019, were screened. International Index of Erectile Function (IIEF-5) questionnaire was given to assess erectile dysfunction (ED). Patients were asked questions regarding their sexual and urinary function from the EORTC-QL CRC 38 questionnaire, and responses were recorded. Patients were also asked to report any retrograde ejaculation in post-operative period. Sixty-two patients were included in the study. Fifty-four patients (87.1%) received a diversion stoma. Sixteen patients (29.6%) felt stoma was interfering with their sexual function. Six patients (9.7%) reported retrograde ejaculation. Only 5 patients (8.06%) had moderate to severe ED, and the rest had none to mild ED. On univariate and multivariate analysis, only age predicted the development of clinically significant ED. Ten patients (16.1%) had significantly reduced sexual urges, and 23 patients (37.1%) had significant decrease in sexual satisfaction after surgery. Five patients (8.06%) reported having minor urinary complaints. No patient reported having major complaint pertaining to urinary health. While long-term urinary complaints are infrequent, almost half the patient suffered from erectile dysfunction in some form. There is a weak but significant association of age and ED. Follow-up clinic visits provide an ideal opportunity to counsel patients and provide any medical intervention, when necessary.

Retroperitoneal liposarcomas are rare malignant tumors known for their slow growth and challenging management, particularly due to their substantial size upon diagnosis. This case report highlights a remarkable instance of a massive retroperitoneal sarcoma concomitant with synchronous renal cell carcinoma.

Ongoing for submission

Ongoing for submission